Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human micro-somal protein and …

ZE Barter, MK Bayliss, PH Beaune… - Current drug …, 2007 - ingentaconnect.com
… Glucose-6-phosphatase (G-6-P) activity was used to correct for microsomal loss and DNA
recovery for cell loss. The 95% CI of the meangeo value of human MPPGL was estimated as …

Human cytochromes P450

…, LS Kaminsky, SD Spivack, E Boitier, P Beaune - Molecular aspects of …, 1999 - Elsevier
The cytochrome P450 proteins (CYPs) are a family of haem proteins resulting from expression
of a gene super-family that currently contains around 1000 members in species ranging …

the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease

L Chouchana, C Narjoz, P Beaune… - Alimentary …, 2012 - Wiley Online Library
… A prospective study on 43 leukaemic patients also indicate that elevated transaminases are
related to high levels of methylated metabolites (P < 0.001). However, in a prospective study …

Optimization of initial tacrolimus dose using pharmacogenetic testing

…, AE Heng, JF Subra, P Beaune… - Clinical …, 2010 - Wiley Online Library
Retrospective studies have demonstrated that patients who are expressors of cytochrome
P4503A5 (CYP3A5) require a higher tacrolimus dose to achieve a therapeutic trough …

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity

…, P Jaillon, P Beaune, P Laurent-Puig… - Blood, 2005 - ashpublications.org
The aim of the study is to explore the contribution of genetic factors related either to drug
metabolism (cytochrome P450 2C9) or to drug target (vitamin K epoxide reductase) to variability …

Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis

…, S Micard, B Landi, H Blons, P Beaune… - … journal of cancer, 2002 - Wiley Online Library
… All tests were 2-sided, and a p-value of less than 0.05 was considered significant. … T 30
and P 30 correspond to the tumor DNA and plasma DNA of patient no. 30. C M and C U …

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

…, L Becquemont, B Cassinat, P Beaune… - Journal of the …, 2003 - journals.lww.com
… (SNP) studied is indicated (arrows) in relation to the exon structure of the MDR1 gene
and the predicted topology of the P-glycoprotein (P-gp). (Adapted from Tanabe et al. ( 9 ).) …

Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP) 1, CYP2 and CYP3 families in 22 different human tissues

…, P Marcellin, R Lidereau, P Beaune… - Pharmacogenetics …, 2007 - journals.lww.com
Objective The aim of this work was to study simultaneously the expression profile of the 23
CYP mRNAs of CYP1, CTP2 and CYP3 families in 22 different human tissues namely adrenal …

Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy

…, PH Cugnenc, R Jian, P Beaune, P Laurent-Puig - Clinical Cancer …, 2004 - AACR
… The number of variant 2R alleles was associated with an increasing OR of toxicity grade
3 or 4 (P trend = 0.002). An OR of 20 (95% CI, 1.5–282) was observed for patients with the …

The increase in urinary excretion of 6 beta‐hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.

…, P Bories, H Michel, P Beaune, P Maurel - British journal of …, 1989 - Wiley Online Library
1. Urinary excretion of 6 beta‐hydroxycortisol, hepatic microsomal cortisol 6 beta‐hydroxylase
and the specific content of several forms of cytochrome P450 were measured in 8 to 14 …